디지털 병리학 시장 - 제품별, 용도별, 최종 용도별 - 세계 예측(2023-2032년)

Global Digital Pathology Market will witness 10.4% CAGR between 2023 and 2032, propelled by continuous launches and innovations by industry leaders. The relentless pursuit of advancements in imaging technologies, AI-driven analysis, and cloud-based solutions by pioneering companies reshapes pathology practices. For instance, in November 2023, Dedalus Group, a leading provider of anatomic pathology information systems in Europe, in collaboration with Ibex Medical Analytics, known for AI-driven cancer diagnostics, introduced an advanced Digital Pathology Solution powered by AI for cancer diagnosis. This integrated solution, merging Ibex's Galen™ platform with comprehensive Digital Pathology Solution by Dedalus, sets a pioneering benchmark in anatomic pathology lab digitization.

Cutting-edge launches enhance diagnostic accuracy, streamline workflows, and enable remote access to medical data, revolutionizing healthcare delivery. This heightened digital pathology market demand reflects the industry's responsiveness to technological breakthroughs, emphasizing the pivotal role of innovation in elevating diagnostic precision and transforming the landscape of pathology services globally.

The overall Digital Pathology Market share is classified based on product, end-use, and region.

Software segment will undergo significant development from 2023 to 2032. Advanced digital pathology software revolutionizes medical diagnostics, offering precision, scalability, and remote accessibility. These software solutions leverage AI, machine learning, and image analysis to enhance pathology workflows, enabling faster and more accurate diagnoses. With a surge in adoption across healthcare facilities worldwide, the digital pathology market share witnesses increased demand for software that empowers pathologists with comprehensive tools, improving efficiency and aiding in complex disease detection and treatment planning.

Digital pathology market size from the hospitals segment will register a noteworthy CAGR from 2023 to 2032. With a focus on improving patient care, hospitals are increasingly adopting digital pathology technologies. These innovations streamline workflows, offer remote access to pathology data, and enhance collaboration among healthcare professionals. Digital pathology tools empower hospitals to expedite diagnoses, improve accuracy, and facilitate seamless integration with existing healthcare systems. The growing recognition of these benefits fuels the escalating digital pathology market demand among healthcare institutions globally.

Europe digital pathology industry will showcase a commendable CAGR from 2023 to 2032. European countries are embracing digital pathology solutions to enhance diagnostic accuracy, streamline workflows, and improve patient care. This surge is bolstered by government initiatives supporting innovative healthcare technologies and the need for remote access to pathology data. As the region increasingly emphasizes precision medicine and advancements in healthcare, the demand for digital pathology systems continues to grow steadily across European healthcare facilities.

For instance, in November 2023, Philips, the pioneering company from the Netherlands that debuted an FDA-approved digital pathology slide scanner for primary diagnostic use in 2017, stood as a trailblazer in the realm of digital pathology. According to the most recent KLAS Research report titled 'U.S. Digital Pathology 2023' Performance Insights, Philips was recognized for possessing "one of the most extensive customer bases for primary diagnosis," both within and beyond the borders of the United States, owing to its commendable digital pathology solutions.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & workings
• 1.3 Forecast calculations
• 1.4 Data Sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Global digital pathology market 360 degree synopsis, 2018 - 2032
• 2.2 Regional trends
• 2.3 Product trends
• 2.4 Application trends
• 2.5 End-use trends

Chapter 3 Digital Pathology Industry Insights

• 3.1 COVID- 19 impact analysis
• 3.2 Industry ecosystem analysis
• 3.3 Technology landscape
• 3.4 Regulatory landscape
• 3.5 Industry impact forces
  • 3.5.1 Growth drivers
    • 3.5.1.1 Increasing adoption of digital solutions
    • 3.5.1.2 Advancements in imaging technology
    • 3.5.1.3 Integration of digital pathology systems with electronic health records (EHRs)
    • 3.5.1.4 Increasing application in drug discovery and companion diagnostics
  • 3.5.2 Industry pitfalls & challenges
    • 3.5.2.1 Lack of standard guidelines for digital pathology
    • 3.5.2.2 High cost associated with the implementation and integration of hardware or software
• 3.6 Growth potential analysis
  • 3.6.1 By product
  • 3.6.2 By application
  • 3.6.3 By end-use
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
  • 4.1.1 Danaher Corporation
  • 4.1.2 Koninklijke Philips N.V
  • 4.1.3 F. Hoffmann-La Roche Ltd
• 4.2 Competitive analysis of major market players, 2022
• 4.3 Competitive positioning matrix, 2022
• 4.4 Strategic outlook matrix, 2022

Chapter 5 Digital Pathology Market Size and Forecast, By Product, 2018-2032 (USD Million)

• 5.1 Key trends, by product
• 5.2 Image analysis software
  • 5.2.1 On-premise
  • 5.2.2 Cloud-based
• 5.3 Scanner
  • 5.3.1 Bright field scanner
  • 5.3.2 Fluorescence scanner
  • 5.3.3 Combination scanner
  • 5.3.4 Other scanners
• 5.4 Services
  • 5.4.1 Installation and integration
  • 5.4.2 Maintenance services
  • 5.4.3 Consulting services

Chapter 6 Digital Pathology Market Size and Forecast, By Application, 2018-2032 (USD Million)

• 6.1 Key trends, by application
• 6.2 Drug discovery & development
• 6.3 Disease diagnosis
• 6.4 Teleconsultation
• 6.5 Other applications

Chapter 7 Digital Pathology Market Size and Forecast, By End-use, 2018-2032 (USD Million)

• 7.1 Key trends, by end-use
• 7.2 Hospitals
• 7.3 Biotech & pharma companies
• 7.4 Diagnostic laboratories
• 7.5 Academic & research institutes
• 7.6 Other end-users

Chapter 8 Digital Pathology Market Size and Forecast, By Region, 2018-2032 (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 3DHISTECH LTD
• 9.2 Danaher Corporation
• 9.3 Glencoe Software Inc.
• 9.4 HAMAMTSU Photonics K.K
• 9.5 Indica Labs Inc.
• 9.6 Koninklijke Philips N.V
• 9.7 Nikon Corporation
• 9.8 Perkinelmer Inc.
• 9.9 F. Hoffmann-La Roche Ltd
• 9.10 VisoPharma A/S.
• 9.11 Olympus Corporation
• 9.12 Leica Biosystems
• 9.13 Proscia Inc.
• 9.14 Mikroscan Technologies Inc
• 9.15 Sectra AG